{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:15:29Z","timestamp":1790709329196,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["108481"],"award-info":[{"award-number":["108481"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study was carried out to determine the prevalence and the genetic background of extended-spectrum \u03b2-lactamase-producing\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      invasive isolates obtained from a tertiary-care hospital in Budapest, Hungary.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Between October\u2013November 2018, all invasive ESBL-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates were collected from Central Hospital of Southern Pest. The antimicrobial susceptibility testing was performed according to the EUCAST guidelines. The possible clonal relationships were investigated by core genome (cg)MLST (SeqSphere\u2009+) using whole-genome sequencing (WGS) data of isolates obtained from Illumina 251-bp paired-end sequencing. From WGS data acquired antimicrobial resistance genes, virulence genes and replicon types were retrieved using ResFinder3.1, PlasmidFinder2.1, pMLST-2.0, VirulenceFinder2.0 and Virulence Factors Database online tools.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, six\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates proved to be resistant to third-generation cephalosporins and ESBL-producers in the study period. Full genome sequence analysis showed that five\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates belonged to the ST131 clone: two to C1-M27 subclade with\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M-27<\/jats:sub>\n                      and three to C2\/H30Rx subclade with\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M-15<\/jats:sub>\n                      . One isolate belonged to ST1193 with\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M-27<\/jats:sub>\n                      . According to cgMLST, all C2\/H30Rx isolates formed a cluster (\u2264\u20096 allele differences), while the\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M-27<\/jats:sub>\n                      -producing C1-M27 isolates differed at least 35 alleles from each other\n                      <jats:italic>.<\/jats:italic>\n                      Both C2\/H30Rx and C1-M27 ST131 isolates harbored similar antimicrobial resistance gene sets. However, only C2\/H30Rx isolates had the\n                      <jats:italic>qnrB<\/jats:italic>\n                      and\n                      <jats:italic>aac(3)-<\/jats:italic>\n                      IIa. The isolates carried similar extraintestinal virulence gene set but differed in some genes encoding siderophores, protectins and toxins. Moreover, only one C2\/H30Rx isolate carried salmochelin siderophore system and showed virotype B. All isolates showed resistance against ceftriaxone, cefotaxime, and ciprofloxacin, and the C2\/H30Rx isolates were also resistant to gentamicin, tobramycin, and ceftazidime.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Out of six ESBL-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      , five belonged to the ST131\u00a0clone. This study indicates, that the C2\/H30Rx and C1-M27 subclades of the ST131 appear to be the dominant clones collected in a Hungarian hospital.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-022-00493-8","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:02:57Z","timestamp":1644476577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Population snapshot of the extended-spectrum \u03b2-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-777X","authenticated-orcid":false,"given":"Kinga","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1kos","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Kamotsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56\u201366.","journal-title":"Lancet Infect Dis"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/fpd.2007.0087","volume":"4","author":"JL Smith","year":"2007","unstructured":"Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis. 2007;4:134\u201363.","journal-title":"Foodborne Pathog Dis"},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.10609.1","volume":"6","author":"JDD Pitout","year":"2017","unstructured":"Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Res. 2017;6:1\u20137.","journal-title":"F1000Res"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/CMR.00116-14","volume":"28","author":"AJ Mathers","year":"2015","unstructured":"Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28:565\u201391.","journal-title":"Clin Microbiol Rev"},{"key":"493_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00121-16","author":"TJ Johnson","year":"2016","unstructured":"Johnson TJ, Danzeisen JL, Youmans B, Case K, Llop K, Munoz-Aguayo J, et al. Separate F-type plasmids have shaped the evolution of the H 30 subclone of Escherichia coli sequence type 131. MSphere. 2016. https:\/\/doi.org\/10.1128\/mSphere.00121-16.","journal-title":"MSphere."},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56763-7","volume":"10","author":"K Kondratyeva","year":"2020","unstructured":"Kondratyeva K, Salmon-Divon M, Navon-Venezia S. Meta-analysis of pandemic Escherichia coli ST131 plasmidome proves restricted plasmid-clade associations. Sci Rep. 2020;10:1\u201311.","journal-title":"Sci Rep"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1128\/JCM.06025-11","volume":"50","author":"G Peirano","year":"2012","unstructured":"Peirano G, Van Der Bij AK, Gregson DB, Pitout JDD. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum \u03b2-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol. 2012;50:294\u20139.","journal-title":"J Clin Microbiol"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"e00337","DOI":"10.1128\/mSphere.00337-18","volume":"3","author":"L Roer","year":"2018","unstructured":"Roer L, Overballe-Petersen S, Hansen F, Sch\u00f8nning K, Wang M, R\u00f8der BL, et al. Escherichia coli sequence type 410 is causing new international high-risk clones. MSphere. 2018;3:e00337-e418.","journal-title":"MSphere."},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2013.00015","volume":"4","author":"F Baquero","year":"2013","unstructured":"Baquero F, Tedim AP, Coque TM. Antibiotic resistance shaping multi-level population biology of bacteria. Front Microbiol. 2013;4:1\u201315.","journal-title":"Front Microbiol"},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00243-19","volume":"63","author":"K Schaufler","year":"2019","unstructured":"Schaufler K, Semmler T, Wieler LH, Trott DJ, Pitout J, Peirano G, et al. Genomic and Functional Analysis of Emerging Virulent and Multidrug-Resistant Escherichia coli Lineage Sequence Type 648. Antimicrob Agents Chemother. 2019;63:1\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1556\/AMicr.60.2013.2.8","volume":"60","author":"\u00c1 T\u00f3th","year":"2013","unstructured":"T\u00f3th \u00c1, Juh\u00e1sz-Kaszanyitzky \u00c9, Mag T, Hajbel-V\u00e9kony G, P\u00e1szti J, Damjanova I. Characterization of extended-spectrum \u03b2 -lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006\u20132007. Acta Microbiol Immunol Hung. 2013;60:175\u201385.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"493_CR12","volume-title":"Surveillance of antimicrobial resistance in Europe 2018","author":"European Centre for Disease Prevention and Control","year":"2019","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018. Stockholm: ECDC; 2019."},{"key":"493_CR13","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. http:\/\/www.eucast.org [Accessed 1 January 2018]"},{"key":"493_CR14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. http:\/\/www.eucast.org [Accessed 1 January 2021]"},{"key":"493_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1101\/gr.074492.107","volume":"18","author":"DR Zerbino","year":"2008","unstructured":"Zerbino DR, Birney E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18:821\u20139.","journal-title":"Genome Res"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/genomeA.00056-18","volume":"6","author":"M Mutti","year":"2018","unstructured":"Mutti M, Sonnevend \u00c1, P\u00e1l T, Junttila S, Ekker H, Galik B, et al. Complete genome sequence of Escherichia coli 81009, a representative of the sequence type 131 C1\u2013M27 clade with a multidrug-resistant phenotype. Genome Announc. 2018;6:1\u20132.","journal-title":"Genome Announc"},{"key":"493_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/genomeA.00736-17","volume":"5","author":"H Ghosh","year":"2017","unstructured":"Ghosh H, Bunk B, Doijad S, Schmiedel J, Falgenhauer L, Spr\u00f6er C, et al. Complete genome sequence of blaCTX-M-27-encoding Escherichia coli strain H105 of sequence type 131 lineage C1\/H30R. Genome Announc. 2017;5:30\u20131.","journal-title":"Genome Announc"},{"key":"493_CR18","first-page":"1","volume":"1","author":"TJ Johnson","year":"2016","unstructured":"Johnson TJ, Danzeisen JL, Youmans B, Case K, Llop K, Munoz-Aguayo J, et al. Separate F-type plasmids have shaped the evolution of the H30 subclone of Escherichia coli sequence type 131. MSphere. 2016;1:1\u201315.","journal-title":"MSphere."},{"key":"493_CR19","first-page":"151","volume":"8","author":"P Sahare","year":"2016","unstructured":"Sahare P, Moon A. In silico modelling of \u03b2-lactam resistant Enterococcus faecalis PBP4 and its interactions with various phyto-ligands. Int J Pharm Pharm Sci. 2016;8:151\u20135.","journal-title":"Int J Pharm Pharm Sci"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3201\/eid2211.160519","volume":"22","author":"Y Matsumura","year":"2016","unstructured":"Matsumura Y, Pitout JDD, Gomi R, Matsuda T, Noguchi T, Yamamoto M, et al. Global Escherichia coli sequence type 131 clade with bla CTX-M-27 gene. Emerg Infect Dis. 2016;22:1900\u20137.","journal-title":"Emerg Infect Dis"},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","volume":"75","author":"V Bortolaia","year":"2020","unstructured":"Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75:3491\u2013500.","journal-title":"J Antimicrob Chemother"},{"key":"493_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03617-13","author":"KG Joensen","year":"2014","unstructured":"Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol. 2014. https:\/\/doi.org\/10.1128\/JCM.03617-13.","journal-title":"J Clin Microbiol"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"D694","DOI":"10.1093\/nar\/gkv1239","volume":"44","author":"L Chen","year":"2016","unstructured":"Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: Hierarchical and refined dataset for big data analysis\u201410 years on. Nucleic Acids Res. 2016;44:D694\u20137.","journal-title":"Nucleic Acids Res"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1128\/JCM.01555-13","volume":"51","author":"J Blanco","year":"2013","unstructured":"Blanco J, Mora A, Mamani R, L\u00f3pez C, Blanco M, Dahbi G, et al. Four main virotypes among extended-spectrum-\u03b2-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol. 2013;51:3358\u201367.","journal-title":"J Clin Microbiol"},{"key":"493_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/1469-0691.12028","volume":"19","author":"MEA de Kraker","year":"2013","unstructured":"de Kraker MEA, Jarlier V, Monen JCM, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect. 2013;19:860\u20138. https:\/\/doi.org\/10.1111\/1469-0691.12028.","journal-title":"Clin Microbiol Infect"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/23744235.2015.1109135","volume":"48","author":"T Martelius","year":"2016","unstructured":"Martelius T, Jalava J, K\u00e4rki T, M\u00f6tt\u00f6nen T, Ollgren J, Lyytik\u00e4inen O. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999\u20132013: Trends, patient characteristics and mortality. Infect Dis (Auckl). 2016;48:229\u201334.","journal-title":"Infect Dis (Auckl)"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10096-018-3292-9","volume":"37","author":"G De Angelis","year":"2018","unstructured":"De Angelis G, Fiori B, Menchinelli G, D\u2019Inzeo T, Liotti FM, Morandotti GA, et al. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007\u20132015). Eur J Clin Microbiol Infect Dis. 2018;37:1627\u201336.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"493_CR28","unstructured":"J\u00e1nv\u00e1ri L, Damjanova I, Topf J, Mag T, Mestyan G, Szolyka G, et al. Countrywide dissemination of CTX-M-27-producing Escherichia coli ST131 subclade C1-M27 in Hungary, 2015-2017. ECCMID 2018 accepted abstract (Poster number P1495)"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/mr.57.1.138-163.1993","volume":"57","author":"KJ Shaw","year":"1993","unstructured":"Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev. 1993;57:138\u201363.","journal-title":"Microbiol Rev"},{"key":"493_CR30","first-page":"1","volume":"63","author":"TJ Johnson","year":"2018","unstructured":"Johnson TJ, Elnekave E, Miller EA, Munoz-Aguayo J, Flores Figueroa C, Johnston B, et al. Phylogenomic analysis of extraintestinal pathogenic Escherichia coli sequence type 1193, an emerging multidrug-resistant clonal group. Antimicrob Agents Chemother. 2018;63:1\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"493_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239924","author":"HM Al-Farsi","year":"2020","unstructured":"Al-Farsi HM, Camporeale A, Ininbergs K, Al-Azri S, Al-Muharrmi Z, Al-Jardani A, et al. Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: a nationwide survey from Oman. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0239924.","journal-title":"PLoS ONE"},{"key":"493_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02294","author":"J Wu","year":"2017","unstructured":"Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 Non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol. 2017. https:\/\/doi.org\/10.3389\/fmicb.2017.02294.","journal-title":"Front Microbiol"},{"key":"493_CR33","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2017.170319","author":"Y Kim","year":"2017","unstructured":"Kim Y, Oh T, Nam Y, Cho S, Lee H. Prevalence of ST131 and ST1193 among bloodstream isolates of Escherichia coli not susceptible to ciprofloxacin in a Tertiary Care University Hospital in Korea, 2013\u20132014. Clin Lab. 2017. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170319.","journal-title":"Clin Lab"},{"key":"493_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jgar.2019.01.014","volume":"17","author":"G Valenza","year":"2019","unstructured":"Valenza G, Werner M, Eisenberger D, Nickel S, Lehner-Reindl V, H\u00f6ller C, et al. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli from Germany. J Glob Antimicrob Resist. 2019;17:305\u20138.","journal-title":"J Glob Antimicrob Resist"},{"key":"493_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jac\/dkz397","volume":"75","author":"J Findlay","year":"2020","unstructured":"Findlay J, Gould VC, North P, Bowker KE, Williams MO, MacGowan AP, et al. Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017\u201318. J Antimicrob Chemother. 2020;75:65\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"493_CR36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.ijmm.2014.10.002","volume":"304","author":"G Dahbi","year":"2014","unstructured":"Dahbi G, Mora A, Mamani R, L\u00f3pez C, Alonso MP, Marzoa J, et al. Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131: comparison with H30 and H30-Rx subclones of O25b: H4-ST131. Int J Med Microbiol. 2014;304:1247\u201357. https:\/\/doi.org\/10.1016\/j.ijmm.2014.10.002.","journal-title":"Int J Med Microbiol"},{"key":"493_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-019-0290-0","volume":"11","author":"J Sarowska","year":"2019","unstructured":"Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: Recent reports. Gut Pathog. 2019;11:1\u201316. https:\/\/doi.org\/10.1186\/s13099-019-0290-0.","journal-title":"Gut Pathog."},{"key":"493_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1086\/653932","volume":"51","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51:286\u201394.","journal-title":"Clin Infect Dis"},{"key":"493_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087025","author":"A Mora","year":"2014","unstructured":"Mora A, Dahbi G, L\u00f3pez C, Mamani R, Marzoa J, Dion S, et al. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0087025.","journal-title":"PLoS ONE"},{"key":"493_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jac\/dkq491","volume":"66","author":"A Coelho","year":"2011","unstructured":"Coelho A, Mora A, Mamani R, L\u00f3pez C, Gonz\u00e1lez-L\u00f3pez JJ, Larrosa MN, et al. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother. 2011;66:517\u201326.","journal-title":"J Antimicrob Chemother"},{"key":"493_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01664-18","author":"JR Johnson","year":"2019","unstructured":"Johnson JR, Johnston BD, Porter SB, Clabots C, Bender TL, Thuras P, et al. Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01664-18.","journal-title":"J Clin Microbiol"},{"key":"493_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","volume":"27","author":"MH Nicolas-Chanoine","year":"2014","unstructured":"Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli st131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543\u201374.","journal-title":"Clin Microbiol Rev"},{"key":"493_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004766","author":"VF Lanza","year":"2014","unstructured":"Lanza VF, de Toro M, Garcill\u00e1n-Barcia MP, Mora A, Blanco J, Coque TM, et al. Plasmid flux in Escherichia coli ST131 sublineages, analyzed by plasmid constellation network (PLACNET), a new method for plasmid reconstruction from whole genome sequences. PLoS Genet. 2014. https:\/\/doi.org\/10.1371\/journal.pgen.1004766.","journal-title":"PLoS Genet"},{"key":"493_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2020.01968","volume":"11","author":"AK Kidsley","year":"2020","unstructured":"Kidsley AK, White RT, Beatson SA, Saputra S, Schembri MA, Gordon D, et al. Companion animals are spillover hosts of the multidrug-resistant human extraintestinal escherichia coli pandemic clones ST131 and ST1193. Front Microbiol. 2020;11:1\u201310.","journal-title":"Front Microbiol"},{"key":"493_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03999.x","author":"A Adler","year":"2012","unstructured":"Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, et al. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect. 2012. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03999.x.","journal-title":"Clin Microbiol Infect"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-022-00493-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:09:48Z","timestamp":1644476988000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-022-00493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s12941-022-00493-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-535213\/v1","asserted-by":"object"}]},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective study, not directly associated with patients and it was consistent with the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approve the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}